Malaria Site: All About Malaria

Malaria has been haunting mankind since evolution. It has killed more people than all the wars, has greatly influenced our history and geography and has changed many of our genes. Globally, ~3.2 billion people are at risk of malaria, and 1.2 billion are at high risk. In 2013, malaria caused 198 million infections and 584 000 deaths; nearly 90% of these deaths occurred in Africa, and 78% occurred in children <5 years. Yet, global malaria funding is half of what is needed. P. falciparum has become resistant to most medicines along the Cambodia–Thailand border and the vector mosquitoes are resistant to insecticides in 49 of 63 reporting countries. Although 64 countries are said to be on track to meet the MDG target of reversing the incidence of malaria, the challenge of malaria continues…

This web site provides comprehensive information on the history, parasites and vectors, pathogenesis, clinical features, diagnosis, treatment, complications and control measures of malaria. It also showcases the malaria control efforts at Mangaluru, South India.

History | Parasites | Vectors | Pathogenesis | Clinical features | Diagnosis | Treatment | Complications | Control | Mangaluru

News Desk
Achieving the malaria MDG target: reversing the incidence of malaria 2000–2015: WHO, UNICEF Report, September 2015 [See]; India 3rd in no. of malaria deaths [TOI Report]
Fluorescence In Situ Hybridization (FISH) Assays for Diagnosing Malaria in Endemic Areas. Jyotsna Shah, Olivia Mark, Helena Weltman, Nicolas Barcelo, Wai Lo, Danuta Wronska, Srinivas Kakkilaya, Aravinda Rao, Shalia T. Bhat, Ruchi Sinha, Sabah Omar, Peter O’bare, Manuel Moro, Robert H. Gilman, Nick Harris. PLOS One. September 2, 2015. DOI: 10.1371/journal.pone.0136726. Full Text at [Times of India Report | Bangalore Mirror Report]
WHO Guidelines for the treatment of malaria: Third edition – 2015 [Full | Policy Advisory Committee Meeting]
Challenge of P. vivax Malaria [WHO Technical Brief | Confronting P. vivax | Baird K on P. vivax mortality | Naing C et al: P. vivax as severe malaria | P. vivax and choroquine resistance]
GlaxoSmithKline (GSK)’s RTS,S, malaria vaccine, Mosquirix, gets approval of The European Medicines Agency (EMA) for use in children in Africa, awaits WHO nod [Guardian | Reuters | WSJ]
New anti-malaria drug developed at Dundee University [Nature | The Hindu | BBC]
Mosquitoes, not Maoists, kill most men in 106 Naxal affected districts of India. [See Report Mar 13, 2015]
Blood Group O protects and blood group A predisposes to severe malaria [See The Hindu | Science Daily | Abstract in Nature Medicine]
12.8 crore suspected malaria cases, 8.81 lakh confirmed cases recorded in India, says WHO World Malaria Report 2014 [See Report | See TOI]
New Software being Developed to Aid Malaria Control in Mangaluru, Supported by Mangalore Medical Relief Society [See]
SMS Reminders Help to Improve Compliance in Malaria Treatment [See News | Plos One Full Text]
Malaria’s Clinical Symptoms Fade on Repeat Infections Due to Loss of Immune Cells, UCSF-Led Team Finds [See]
guidelines-3rded-coverWorld Malaria Report 2014 Severe Malaria: WHO, 2012 Severe Malaria Supplement 2014 National Drug Policy India 2013

 © ©BS Kakkilaya | Last Updated: Sep 21, 2015

Leave a Reply

Your email address will not be published. Required fields are marked *